LeMaitre Vascular, Inc. (LMAT) News
Follow LeMaitre Vascular, Inc. (LMAT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
LeMaitre Vascular Reports Third-Quarter Revenue of $67.97 Million, EPS of $0.65
Third-quarter net sales rose 11% year over year, while net income declined. The company cited higher average selling prices and unit volumes, plus international Artegraft sales following its European launch.
EQUITY | Nov 05, 2026, 11:41 AM UTC
M
LeMaitre Vascular Q3 Sales Slightly Beat Estimates
LeMaitre Vascular said third-quarter sales slightly exceeded estimates, citing EMEA performance.
EARNINGS | Nov 04, 2026, 10:19 PM UTC
M
LeMaitre to announce third-quarter 2026 results November 4
EQUITY | Oct 12, 2026, 08:49 PM UTC
L
LeMaitre to participate in investor conferences in September
LeMaitre said it will participate in upcoming investor conferences in September.
EQUITY | Aug 27, 2026, 08:51 PM UTC
L
LeMaitre Vascular Lowers FY2026 GAAP EPS Guidance from $2.93-$3.08 to $2.84-$2.94 vs $2.97 Est; Lowers FY2026 Sales Guidance from $277.000M
LeMaitre Vascular (NASDAQ: LMAT ) lowers FY2026 GAAP EPS guidance from $2.93-$3.08 to $2.84-$2.94 vs $2.97 analyst estimate. Lowers FY2026 sales outlook from $277.000 million-$283.000 million to $274.300 million-$278.300
EARNINGS | Aug 04, 2026, 08:25 PM UTC
L
LMAT - LeMaitre Q2 2026 Financial Results
LMAT - LeMaitre Q2 2026 Financial Results
EARNINGS | Aug 04, 2026, 08:07 PM UTC
L
LMAT - Over the weekend Herb Greenberg published a negative piece on Lemaitre Vascular: "Red Flag Alert – The 'Pricing' of Success for Lemai
LMAT - Over the weekend Herb Greenberg published a negative piece on Lemaitre Vascular: "Red Flag Alert – The 'Pricing' of Success for Lemaitre. Valued as a growing, durable Medtech compounder, but has its model met its
EQUITY | Jul 20, 2026, 12:13 PM UTC